Event Videos

Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

http://www.ncbi.nlm.nih.gov/pubmed/25179168

Thabut D, Rudler M, Dib N, Carbonell N, Mathurin P, Saliba F, Mallet A, Massard J, Bernard-Chabert B, Oberti F, Cales P, Golmard JL, Bureau C; French Club for the Study of Portal Hypertension (CFEHTP). Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology. 2015 Mar; 61(3):1024-32.

Abstract

Published on: 
Mar-2015
Read more

Pharmacologic treatment in pediatric functional abdominal pain disorders: a systematic review

http://www.ncbi.nlm.nih.gov/pubmed/25449223

Korterink JJ, Rutten JM, Venmans L, Benninga MA, Tabbers MM. Pharmacologic treatment in pediatric functional abdominal pain disorders: a systematic review. J Pediatr. 2015 Feb; 166(2): 424-431.e6.

Abstract

OBJECTIVE:
To systematically review literature assessing efficacy and safety of pharmacologic treatments in children with abdominal pain-relatedfunctional gastrointestinal disorders (AP-FGIDs).

STUDY DESIGN:
MEDLINE and Cochrane Database were searched for systematic reviews and randomized controlled trials investigating efficacy and safety of pharmacologic agents in children aged 4-18 years with AP-FGIDs. Quality of evidence was assessed using Grades of Recommendation, Assessment, Development and Evaluation approach.

Published on: 
Feb-2015
Read more

Plasma cathepsin d levels: a novel tool to predict pediatric hepatic inflammation

http://www.ncbi.nlm.nih.gov/pubmed/25732418

Plasma cathepsin d levels: a novel tool to predict pediatric hepatic inflammation.

Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vreugdenhil AC, Adriaanse MP, Buurman WA, Hofker MH, Mosca A, Lindsey PJ, Alisi A, Liccardo D, Panera N, Koek GH, Nobili V, Shiri-Sverdlov R. Plasma cathepsin d levels: a novel tool to predict pediatric hepatic inflammation. Am J Gastroenterol. 2015 Mar;110(3):462-70.

Abstract

Published on: 
Mar-2015
Read more

Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension.

http://www.ncbi.nlm.nih.gov/pubmed/25250684

Celtik C, Durmaz O, Oner N, Yavuz T, Gökce S, Aydogan A, Nisli K, Emiroglu HH, Ömeroglu RE, Sökücü S. Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2): 177-81.

Abstract

BACKGROUND:
Cirrhotic cardiomyopathy (CCMP) is a functional disorder characterized by electrophysiological disturbances, and diastolic and/or systolic dysfunction in patients with liver disease. This disorder is a well-defined entity in adults, but pediatric data are limited. The aim of the study was to determine the incidence, features, and risk factors of CCMP in children with portal hypertension (PHT).

METHODS:

Published on: 
Feb-2015
Read more

Fulminant hepatic failure of autoimmune aetiology in children

http://www.ncbi.nlm.nih.gov/pubmed/25304891

Di Giorgio A, Bravi M, Bonanomi E, Alessio G, Sonzogni A, Zen Y, Colledan M, D'Antiga L. Fulminant hepatic failure of autoimmune aetiology in children. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2): 159-64.

Abstract

OBJECTIVE:
Autoimmune hepatitis (AIH) is considered an underdiagnosed cause of fulminant hepatic failure (FHF). Autoimmune FHF (AI-FHF) is believed to lead invariably to liver transplantation (LTX) or death. We aimed to describe the autoimmune features of children diagnosed as having AI-FHF and indeterminate FHF (ID-FHF), and describe the outcome of patients with AI-FHF treated with immunosuppressive drugs.

METHODS:

Published on: 
Feb-2015
Read more
« first ‹ previous … 131 132 133 134 135 136 137 138 139 … next › last »

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: